Clinical Trial Update: An Investigation of TAS-119 Monotherapy [Phase 1]

View source ↗

Summary

The update covers TAS-119 given as monotherapy in a Phase 1 trial for patients with advanced solid tumors; the study (NCT02448589) sponsored by Taiho Oncology h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• TAS-119 (tas-119)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Advanced Solid Tumors | Phase 1 | Status: TERMINATED